|
|
JAMA: Fish oil RCT shows some benefit in terms of AV grafts, but primary outcome was negative. |
|
JAMA: Conclusions Among patients with new hemodialysis grafts, daily fish oil ingestion did not decrease the proportion of grafts with loss of native patency within 12 months. Although fish oil improved some relevant secondary outcomes such as graft patency, rates of thrombosis, and interventions, other potential benefits on cardiovascular events require confirmation in future studies.
|
|
|
Mechanism of increased CV risk with NSAIDs explained. |
|
EurekAlert: "However, it's not all bad news," says FitzGerald. This risk of hardening of the arteries was diminished in mice by reducing leukotriene formation, via blocking a critical protein called the 5-lipoxygenase activating protein, or FLAP. Inhibitors of FLAP are already in trials in humans to see if they work in asthma. Perhaps, FitzGerald concludes, they can now find an additional use -- protecting the heart from NSAIDs.
|
|
Rethinking the medical school class lecture model. |
|
EurekAlert: Prober also has been working closely with Salman "Sal" Khan, the Silicon Valley-based online learning pioneer whose nonprofit effort, Khan Academy, is widely credited, in the words of Bill Gates, for having "turned the classroom — and the world of education — on its head." Prober and Heath's perspective piece proposes a Khan Academy-styled "flipped-classroom" model of teaching. Lecture content is packaged in 10- to 15-minute videos that are watched by the students at their own pace and as often as necessary to learn the material. Class time is then freed up for more interactive education, with greater emphasis on patients' clinical stories as a way to increase the relevance of the necessary scientific and medical knowledge.
|
|
Aspirin and warfarin equally effective in heart failure patients. |
|
EurekAlert: Long-awaited results of 1 of the largest-ever studies of heart failure could mean that more doctors and their patients will choose less costly aspirin therapy Neither aspirin nor warfarin is superior for preventing a combined risk of death, stroke, and cerebral hemorrhage in heart failure patients with normal heart rhythm, according to a landmark clinical trial published in today's New England Journal of Medicine.
|
|
Combination of two mTor inhibitors reverses liver tumor growth. |
|
Idibell: The combination of two inhibitors of protein mTOR stops the growth of primary liver cancer and destroys tumour cells, according to a study by researchers of the Group of Metabolism and Cancer at Bellvitge Biomedical Research Institute (IDIBELL). The study results are been published on the online edition of the journal Science Translational Medicine.
|
|
|
|
|
<< Start < Prev 401 402 403 404 405 406 407 408 409 410 Next > End >>
|
|
Page 404 of 2630 |
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
